Last Posted: Feb 20, 2021
- Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase.
Valero Cristina et al. JAMA oncology 2021 Feb - Germline pathogenic variants in the Ataxia Telangiectasia Mutated (ATM) gene are associated with high and moderate risks for multiple cancers.
Hall Michael J et al. Cancer prevention research (Philadelphia, Pa.) 2021 Jan - Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.
Chittenden Anu et al. JCO oncology practice 2021 Jan OP2000678 - Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort.
Peretti U et al. ESMO open 2021 Jan 6(1) 100032 - Possible Association of PER2/PER3 Variable Number Tandem Repeat Polymorphism Variants with Susceptibility and Clinical Characteristics in Pancreatic Cancer.
Dagmura Hasan et al. Genetic testing and molecular biomarkers 2020 Dec - Genetic Abnormalities in Pancreatitis: An Update on Diagnosis, Clinical Features, and Treatment.
Suzuki Mitsuyoshi et al. Diagnostics (Basel, Switzerland) 2020 Dec 11(1) - Pure and Hybrid Deep Learning Models can Predict Pathologic Tumor Response to Neoadjuvant Therapy in Pancreatic Adenocarcinoma: A Pilot Study.
Watson Michael D et al. The American surgeon 2020 Dec 3134820982557 - Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study.
Karamitopoulou Eva et al. Virchows Archiv : an international journal of pathology 2020 Dec - Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors.
Sá Bianca Costa Soares de et al. Anais brasileiros de dermatologia 93(3) 337-340 - Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study.
Appelbaum Limor et al. European journal of cancer (Oxford, England : 1990) 2020 Dec 14319-30
Search Result Summary
- CDC Information (0)
- NIH Information (5)
- CDC Publications (0)
- Human Genome Epidemiologic Studies (626)
- GWAS Studies (14)
- Human Genomics Translation/Implementation Studies (125)
- Genomic Tests Evidence Synthesis (17)
- Genomic Tests Guidelines (9)
- Tier-Classified Guidelines (4)
- Non-Genomics Precision Health (10)
- Pathogen Advanced Molecular Detection (3)
- State Public Health Genomics Programs (7)
- Ethical/Legal and Social Issues (ELSI) (0)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 01, 2021
- Content source: